These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 32652364)
1. Stress and cancer. Part II: Therapeutic implications for oncology. Mravec B; Tibensky M; Horvathova L J Neuroimmunol; 2020 Jul; 346():577312. PubMed ID: 32652364 [TBL] [Abstract][Full Text] [Related]
2. Stress and cancer. Part I: Mechanisms mediating the effect of stressors on cancer. Mravec B; Tibensky M; Horvathova L J Neuroimmunol; 2020 Jul; 346():577311. PubMed ID: 32652365 [TBL] [Abstract][Full Text] [Related]
3. Neurobiology of cancer: Definition, historical overview, and clinical implications. Mravec B Cancer Med; 2022 Feb; 11(4):903-921. PubMed ID: 34953048 [TBL] [Abstract][Full Text] [Related]
4. Neurobiology of Cancer: the Role of β-Adrenergic Receptor Signaling in Various Tumor Environments. Mravec B; Horvathova L; Hunakova L Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33114769 [TBL] [Abstract][Full Text] [Related]
5. Stress reduction strategies in breast cancer: review of pharmacologic and non-pharmacologic based strategies. Gosain R; Gage-Bouchard E; Ambrosone C; Repasky E; Gandhi S Semin Immunopathol; 2020 Dec; 42(6):719-734. PubMed ID: 32948909 [TBL] [Abstract][Full Text] [Related]
6. Psychoneuro-oncology: How chronic stress grows cancer. Tausk F Clin Dermatol; 2023; 41(1):95-104. PubMed ID: 36882133 [TBL] [Abstract][Full Text] [Related]
7. Sympathoadrenal system in stress. Interaction with the hypothalamic-pituitary-adrenocortical system. Kvetnanský R; Pacák K; Fukuhara K; Viskupic E; Hiremagalur B; Nankova B; Goldstein DS; Sabban EL; Kopin IJ Ann N Y Acad Sci; 1995 Dec; 771():131-58. PubMed ID: 8597393 [TBL] [Abstract][Full Text] [Related]
8. Stress-induced norepinephrine release in the hypothalamic paraventricular nucleus and pituitary-adrenocortical and sympathoadrenal activity: in vivo microdialysis studies. Pacak K; Palkovits M; Kopin IJ; Goldstein DS Front Neuroendocrinol; 1995 Apr; 16(2):89-150. PubMed ID: 7621982 [TBL] [Abstract][Full Text] [Related]
9. Psychoneuroimmunology of Cancer - Recent Findings and Perspectives. Mravec B; Tibenský M; Horváthová Ľ Klin Onkol; 2018; 31(5):345-352. PubMed ID: 30541320 [TBL] [Abstract][Full Text] [Related]
10. Stress-induced activation of the sympathoadrenal system is determined by genetic background in rat models of tauopathy. Lejavova K; Ondicova K; Horvathova L; Hegedusova N; Cubinkova V; Vargovic P; Manz G; Filipcik P; Mravec B; Novak M; Kvetnansky R J Alzheimers Dis; 2015; 43(4):1157-61. PubMed ID: 25147110 [TBL] [Abstract][Full Text] [Related]
11. Brain angiotensin II modulates sympathoadrenal and hypothalamic pituitary adrenocortical activation during stress. Jezova D; Ochedalski T; Kiss A; Aguilera G J Neuroendocrinol; 1998 Jan; 10(1):67-72. PubMed ID: 9510060 [TBL] [Abstract][Full Text] [Related]
12. Mind matters in cancer survival. Spiegel D Psychooncology; 2012 Jun; 21(6):588-93. PubMed ID: 22438289 [TBL] [Abstract][Full Text] [Related]
13. Role of catecholamine-induced activation of vagal afferent pathways in regulation of sympathoadrenal system activity: negative feedback loop of stress response. Mravec B Endocr Regul; 2011 Jan; 45(1):37-41. PubMed ID: 21314209 [TBL] [Abstract][Full Text] [Related]
14. Reduced hypothalamic-pituitary and sympathoadrenal responses to hypoglycemia in women with fibromyalgia syndrome. Adler GK; Kinsley BT; Hurwitz S; Mossey CJ; Goldenberg DL Am J Med; 1999 May; 106(5):534-43. PubMed ID: 10335725 [TBL] [Abstract][Full Text] [Related]
15. Central corticotropin-releasing hormone receptors modulate hypothalamic-pituitary-adrenocortical and sympathoadrenal activity during stress. Jezova D; Ochedalski T; Glickman M; Kiss A; Aguilera G Neuroscience; 1999; 94(3):797-802. PubMed ID: 10579570 [TBL] [Abstract][Full Text] [Related]
16. Sound stress-induced long-term enhancement of mechanical hyperalgesia in rats is maintained by sympathoadrenal catecholamines. Khasar SG; Dina OA; Green PG; Levine JD J Pain; 2009 Oct; 10(10):1073-7. PubMed ID: 19576859 [TBL] [Abstract][Full Text] [Related]
17. Hypothalamic-pituitary-adrenal (HPA) axis suppression after treatment with glucocorticoid therapy for childhood acute lymphoblastic leukaemia. Rensen N; Gemke RJ; van Dalen EC; Rotteveel J; Kaspers GJ Cochrane Database Syst Rev; 2017 Nov; 11(11):CD008727. PubMed ID: 29106702 [TBL] [Abstract][Full Text] [Related]
18. Administration of RU 486 for 8 days in normal volunteers: antiglucocorticoid effect with no evidence of peripheral cortisol deprivation. Bertagna X; Escourolle H; Pinquier JL; Coste J; Raux-Demay MC; Perles P; Silvestre L; Luton JP; Strauch G J Clin Endocrinol Metab; 1994 Feb; 78(2):375-80. PubMed ID: 8106625 [TBL] [Abstract][Full Text] [Related]
19. Hyperprolactinemia does not influence hypothalamic-pituitary-adrenocortical function during hypoglycemia in women. Imrich R; Rovensky J; Cervenakova Z; Ksinantova L; Kvetnansky R; Koska J Int J Tissue React; 2002; 24(2):73-8. PubMed ID: 12182236 [TBL] [Abstract][Full Text] [Related]